WEBSITE BSE:500412 NSE : THIRUMALAI 10 May, 16:01
Market Cap ₹2628 Cr.
Stock P/E -84.4
P/B 2.2
Current Price ₹256.7
Book Value ₹ 116.2
Face Value 1
52W High ₹289.4
Dividend Yield 0.58%
52W Low ₹ 175.5
Thirumalai Chemicals Ltd is an totally India-based corporation, that's engaged in manufacturing and selling chemicals. The Company's segments include Chemical products and power generation from wind operated generators. The Company's merchandise include phthalic anhydride, which gives applications, including manufacturing of polyester polyols, phthalate esters, dyes and polyester resin, among others; maleic anhydride, which is used within the manufacture of fumaric and malic acid, lubricating oil additives and tartaric acid, amongst others; malic acid, which is used in liquids, confectionery, preserves and bakery merchandise; fumaric acid, that's used to acidity sweets, wine, fruit juices, drinks, jams and preserves, jellies, gelatin dessert and pie filling; diethyl phthalate (DEP), and chemical substances. It offers chemicals, consisting of succinic acid and succinic anhydride, which offer applications in industries, which includes food, pharmaceutical, agriculture and industrial.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 477 | 541 | 583 | 621 | 572 | 508 | 431 | 523 | 542 | 492 |
Other Income | 4 | 3 | 3 | 3 | 6 | 11 | 11 | 5 | 6 | 4 |
Total Income | 482 | 544 | 586 | 624 | 578 | 519 | 442 | 527 | 549 | 496 |
Total Expenditure | 394 | 425 | 444 | 525 | 511 | 479 | 432 | 485 | 527 | 498 |
Operating Profit | 88 | 119 | 141 | 100 | 67 | 39 | 10 | 42 | 22 | -2 |
Interest | 5 | 5 | 6 | 6 | 7 | 11 | 7 | 10 | 10 | 12 |
Depreciation | 15 | 14 | 15 | 13 | 13 | 14 | 16 | 16 | 16 | 15 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 68 | 100 | 120 | 81 | 47 | 14 | -13 | 17 | -4 | -29 |
Provision for Tax | 17 | 25 | 30 | 21 | 13 | 6 | 0 | 6 | 2 | -6 |
Profit After Tax | 51 | 75 | 90 | 60 | 34 | 8 | -13 | 11 | -6 | -23 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 51 | 75 | 90 | 60 | 34 | 8 | -13 | 11 | -6 | -23 |
Adjusted Earnings Per Share | 4.9 | 7.4 | 8.8 | 5.9 | 3.4 | 0.8 | -1.3 | 1 | -0.6 | -2.2 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1371 | 1276 | 1072 | 944 | 1028 | 1312 | 1261 | 1085 | 1086 | 1998 | 2132 | 1988 |
Other Income | 5 | 5 | 8 | 5 | 4 | 7 | 12 | 21 | 7 | 12 | 30 | 26 |
Total Income | 1376 | 1281 | 1080 | 949 | 1033 | 1319 | 1273 | 1106 | 1093 | 2010 | 2162 | 2014 |
Total Expenditure | 1236 | 1194 | 1034 | 846 | 871 | 1022 | 1055 | 1007 | 865 | 1557 | 1946 | 1942 |
Operating Profit | 140 | 86 | 46 | 103 | 162 | 296 | 217 | 99 | 228 | 452 | 216 | 72 |
Interest | 52 | 49 | 35 | 23 | 17 | 13 | 12 | 17 | 21 | 20 | 31 | 39 |
Depreciation | 23 | 23 | 18 | 25 | 36 | 31 | 36 | 44 | 50 | 57 | 56 | 63 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 64 | 15 | -7 | 55 | 109 | 253 | 169 | 38 | 157 | 375 | 129 | -29 |
Provision for Tax | 21 | 3 | 7 | 23 | 39 | 83 | 55 | 15 | 39 | 94 | 40 | 2 |
Profit After Tax | 44 | 12 | -14 | 32 | 71 | 170 | 114 | 23 | 118 | 281 | 90 | -31 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 44 | 12 | -14 | 32 | 71 | 170 | 114 | 23 | 118 | 281 | 90 | -31 |
Adjusted Earnings Per Share | 4.3 | 1.2 | -1.3 | 3.1 | 6.9 | 16.6 | 11.1 | 2.3 | 11.5 | 27.5 | 8.8 | -3.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 7% | 25% | 10% | 5% |
Operating Profit CAGR | -52% | 30% | -6% | 4% |
PAT CAGR | -68% | 58% | -12% | 7% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 28% | 37% | 27% | 40% |
ROE Average | 8% | 18% | 15% | 16% |
ROCE Average | 11% | 22% | 20% | 23% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 199 | 215 | 193 | 219 | 398 | 573 | 668 | 638 | 803 | 1085 | 1192 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 107 | 60 | 39 | 24 | 12 | 50 | 78 | 184 | 158 | 135 | 148 |
Other Non-Current Liabilities | 26 | 28 | 28 | 27 | 49 | 133 | 261 | 77 | 81 | 86 | 155 |
Total Current Liabilities | 461 | 456 | 287 | 251 | 327 | 217 | 328 | 301 | 301 | 555 | 866 |
Total Liabilities | 793 | 758 | 547 | 520 | 786 | 973 | 1335 | 1200 | 1343 | 1862 | 2360 |
Fixed Assets | 249 | 230 | 243 | 256 | 317 | 310 | 383 | 550 | 513 | 596 | 671 |
Other Non-Current Assets | 30 | 39 | 28 | 38 | 100 | 253 | 493 | 151 | 258 | 235 | 637 |
Total Current Assets | 514 | 489 | 276 | 227 | 368 | 409 | 459 | 499 | 573 | 1031 | 1053 |
Total Assets | 793 | 758 | 547 | 520 | 786 | 973 | 1335 | 1200 | 1343 | 1862 | 2360 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 12 | 6 | 9 | 1 | 1 | 13 | 24 | 53 | 202 | 227 | 425 |
Cash Flow from Operating Activities | 19 | 133 | 154 | 126 | 108 | 81 | 234 | 140 | 221 | 402 | 54 |
Cash Flow from Investing Activities | -0 | -15 | -19 | -32 | -44 | -54 | -220 | -38 | -157 | -139 | -359 |
Cash Flow from Financing Activities | -26 | -116 | -142 | -93 | -52 | -16 | 16 | 46 | -38 | -70 | 206 |
Net Cash Inflow / Outflow | -7 | 3 | -8 | 0 | 12 | 10 | 29 | 148 | 25 | 194 | -99 |
Closing Cash & Cash Equivalent | 6 | 9 | 1 | 1 | 13 | 24 | 53 | 202 | 227 | 425 | 350 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 4.28 | 1.16 | -1.34 | 3.14 | 6.9 | 16.64 | 11.09 | 2.26 | 11.49 | 27.46 | 8.77 |
CEPS(Rs) | 6.51 | 3.4 | 0.4 | 5.59 | 10.4 | 19.63 | 14.64 | 6.57 | 16.33 | 32.99 | 14.21 |
DPS(Rs) | 0.75 | 0 | 0.4 | 1 | 1.88 | 2 | 2 | 0 | 2.2 | 2.5 | 1.5 |
Book NAV/Share(Rs) | 19.43 | 21.01 | 18.86 | 21.36 | 38.89 | 55.95 | 65.22 | 62.32 | 78.41 | 105.96 | 116.4 |
Core EBITDA Margin(%) | 8.99 | 5.89 | 3.26 | 9.56 | 14.13 | 21.65 | 16.33 | 7.2 | 20.33 | 22.06 | 8.73 |
EBIT Margin(%) | 7.79 | 4.57 | 2.39 | 7.61 | 11.29 | 19.87 | 14.36 | 5.07 | 16.4 | 19.8 | 7.53 |
Pre Tax Margin(%) | 4.3 | 1.07 | -0.58 | 5.36 | 9.79 | 18.92 | 13.39 | 3.52 | 14.47 | 18.79 | 6.07 |
PAT Margin (%) | 2.92 | 0.85 | -1.18 | 3.14 | 6.33 | 12.74 | 9.01 | 2.14 | 10.84 | 14.07 | 4.21 |
Cash Profit Margin (%) | 4.45 | 2.51 | 0.35 | 5.6 | 9.55 | 15.03 | 11.89 | 6.2 | 15.4 | 16.91 | 6.82 |
ROA(%) | 5.65 | 1.53 | -2.1 | 6.03 | 10.82 | 19.37 | 9.84 | 1.83 | 9.26 | 17.55 | 4.26 |
ROE(%) | 24.82 | 5.73 | -6.72 | 15.61 | 22.91 | 35.1 | 18.31 | 3.55 | 16.33 | 29.79 | 7.89 |
ROCE(%) | 24.86 | 13.06 | 7 | 24.18 | 32.75 | 49.1 | 25.97 | 6.84 | 19.56 | 35.47 | 11.16 |
Receivable days | 65.56 | 67.51 | 59.78 | 50.14 | 43.73 | 35.13 | 33.6 | 34.15 | 29.83 | 22.23 | 22.09 |
Inventory Days | 43.02 | 52.84 | 47.83 | 29.8 | 36.11 | 37.88 | 45.89 | 56.81 | 46.74 | 34.11 | 48.03 |
Payable days | 20.84 | 46.7 | 54.1 | 70.16 | 114.25 | 86.31 | 84.49 | 125.15 | 138.25 | 105.69 | 114.58 |
PER(x) | 2.17 | 7.67 | 0 | 5.73 | 12.82 | 10.26 | 8.01 | 15.6 | 7.44 | 9.69 | 19.59 |
Price/Book(x) | 0.48 | 0.42 | 0.43 | 0.84 | 2.28 | 3.05 | 1.36 | 0.57 | 1.09 | 2.51 | 1.48 |
Dividend Yield(%) | 8.07 | 0 | 4.93 | 5.56 | 2.12 | 1.17 | 2.25 | 0 | 2.57 | 0.94 | 0.87 |
EV/Net Sales(x) | 0.28 | 0.25 | 0.2 | 0.28 | 0.91 | 1.33 | 0.76 | 0.32 | 0.69 | 1.17 | 0.78 |
EV/Core EBITDA(x) | 2.79 | 3.67 | 4.68 | 2.53 | 5.76 | 5.91 | 4.39 | 3.48 | 3.29 | 5.16 | 7.66 |
Net Sales Growth(%) | 30.1 | -6.93 | -15.98 | -11.95 | 8.93 | 27.57 | -3.88 | -13.98 | 0.09 | 84.04 | 6.71 |
EBIT Growth(%) | 113.69 | -45.69 | -55.99 | 179.12 | 61.77 | 110.98 | -31.9 | -69.63 | 223.89 | 122.28 | -59.4 |
PAT Growth(%) | 4671.38 | -72.91 | -215.66 | 334.26 | 119.8 | 141.18 | -33.37 | -79.6 | 407.94 | 138.96 | -68.06 |
EPS Growth(%) | 4670.01 | -72.91 | -215.66 | 334.26 | 119.78 | 141.18 | -33.37 | -79.6 | 407.94 | 138.96 | -68.06 |
Debt/Equity(x) | 1.56 | 1.15 | 0.73 | 0.42 | 0.15 | 0.09 | 0.15 | 0.31 | 0.23 | 0.15 | 0.37 |
Current Ratio(x) | 1.12 | 1.07 | 0.96 | 0.9 | 1.12 | 1.89 | 1.4 | 1.66 | 1.9 | 1.86 | 1.22 |
Quick Ratio(x) | 0.69 | 0.62 | 0.62 | 0.63 | 0.66 | 1.31 | 0.82 | 1.17 | 1.47 | 1.42 | 0.85 |
Interest Cover(x) | 2.23 | 1.31 | 0.8 | 3.38 | 7.54 | 20.72 | 14.88 | 3.27 | 8.51 | 19.43 | 5.14 |
Total Debt/Mcap(x) | 3.26 | 2.72 | 1.7 | 0.49 | 0.07 | 0.03 | 0.11 | 0.55 | 0.21 | 0.06 | 0.25 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 41.98 | 41.98 | 41.98 | 41.98 | 42 | 42.07 | 42.16 | 42.17 | 41.98 | 41.95 |
FII | 1.89 | 1.29 | 2.67 | 2.5 | 1.99 | 2.14 | 1.8 | 1.86 | 1.88 | 2.17 |
DII | 0.71 | 0.72 | 0.71 | 0.01 | 0.01 | 0.01 | 0.11 | 0.16 | 0.18 | 0.55 |
Public | 55.42 | 56.01 | 54.64 | 55.5 | 55.99 | 55.78 | 55.93 | 55.81 | 55.97 | 55.34 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.31 | 4.32 | 4.32 | 4.3 | 4.29 |
FII | 0.19 | 0.13 | 0.27 | 0.26 | 0.2 | 0.22 | 0.18 | 0.19 | 0.19 | 0.22 |
DII | 0.07 | 0.07 | 0.07 | 0 | 0 | 0 | 0.01 | 0.02 | 0.02 | 0.06 |
Public | 5.67 | 5.74 | 5.59 | 5.68 | 5.73 | 5.71 | 5.73 | 5.71 | 5.73 | 5.67 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10.24 | 10.24 | 10.24 | 10.24 | 10.24 | 10.24 | 10.24 | 10.24 | 10.24 | 10.24 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About